[DOI] [PubMed] [Google Scholar] 98.Turkovic B., Sikiric P., Seiwerth S., Mise S., Anic T., Petek M
As always, patients should work closely with their healthcare providers to determine if this therapy is right for them, weigh the benefits against side effects, and ensure its integrated safely with their overall care
What honest evaluation requires acknowledging: BPC-157 has no FDA-approved human therapeutic application
Adding semaglutide or tirzepatide adds redundant GLP-1 (and GIP, in the case of tirzepatide) activity without new pathway coverage
Conclusion: Clinical Translation and Future Perspectives BPC-157 represents a promising investigational peptide with extensive preclinical evidence supporting tissue regeneration, cytoprotection, and healing enhancement across multiple organ systems